Medication error affecting newborns' sight: a national response. by Mwangi, Nyawira & Gichangi, Michael Mbee
LSHTM Research Online
Mwangi, Nyawira; Gichangi, Michael Mbee; (2019) Medication error affecting newborns’
sight: a national response. Community eye health, 32 (106). p. 32. ISSN 0953-6833
https://www.cehjournal.org/when-something-goes-wro...
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4656260/
DOI:
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
https://researchonline.lshtm.ac.uk
32   COMMUNITY EYE HEALTH JOURNAL | VOLUME 32 | NUMBER 106 | 2019
CASE STUDY: KENYA
Reference
1 World Health 
Organization 
Information 
Exchange System 
Alert No. 133. 
Chlorhexidine 7,1% 
digluconate (CHX) 
aqueous solution or 
gel (10ml): Reports 
of serious eye injury 
due to errors in 
administration. 
February 2019. 
www.who.int/
maternal_child_
adolescent/
news_events/
news/
chlorhexidine-
digluconate-chx-
possible-serious-
eye-injury/en/ 
Chlorhexidine is an antiseptic recommended by the World Health Organisation for use on the umbilical cord in order to prevent neonatal sepsis. It must be 
applied when the cord is cut and for six days afterwards. 
The packaging used resembles eye drop bottles, and 
reports indicate that some mothers therefore confuse 
the antiseptic with eye drops and instil it in their babies’ 
eyes. At the concentration of 7.1%, chlorhexidine is toxic 
to the cornea and can cause permanent visual loss. This 
has been reported in other countries previously.1 
Q: What is the situation now?
Publicity and discussion of this issue in mainstream 
and social media has allowed the public, the eye care 
community, pharmacists, paediatricians, eye care 
managers and other stakeholders to become aware of 
this important issue. 
Patient safety is receiving growing attention in Kenya, 
and eye care providers are on the alert. We are 
discussing the issue at conferences, and we are also 
examining the broad factors that have contributed 
to the error, including manufacturing, packaging, 
importing and dispensing, as well as the way errors 
are reported and handled. This has strengthened the 
health system, as the processes of reporting medication 
errors and investigating them has now become clearer.  
Q: How are you dealing with this problem?
We are working with Kenya’s national Pharmacy and 
Poisons Board (PPB), which is receiving the reports 
and investigating the errors, and we are also having 
conversations with the manufacturers about changing 
the packaging to avoid confusion with eye drops. 
There is also a need to educate the mother or carer when 
dispensing the drugs; it is not enough to tell them: “These 
are your drugs to take home.” It is important to explain 
how to use the medication. We are encouraging reporting 
as well as quick diagnosis, treatment and counselling. 
We are therefore training health care workers to do the 
following: 
• When dispensing 
chlorhexidine, inform 
mothers that the antiseptic 
is for the umbilical cord 
only, not the eye.
• Advise mothers to seek 
immediate help if such an 
incident occurs. If near a 
health facility, they should rush the baby for prompt 
skilled health care. If far from a health facility, they 
should irrigate the eye with clean running tap water.
• Provide emergency care to any babies affected: 
irrigate the eye with normal saline, apply a topical 
anaesthetic, give an oral painkiller and refer the 
baby to an ophthalmologist as soon as possible. 
• Report all incidents. The PPB has requested that 
health workers report each incident of this error 
on a specified reporting form in order to generate 
evidence for action.
Q: What are the challenges with medical errors in 
Kenya, more broadly? 
Many medical errors are not reported. Alternative 
approaches are needed to identify a much higher 
proportion of the errors that actually occur and go 
unreported. 
There are many barriers that currently prevent the 
reporting of errors. To increase our opportunities to learn 
from errors, the following three changes are needed:
1 A more open culture of discussing errors, including 
discussing them at professional forums.
2 Increasing awareness amongst health workers 
about the reporting mechanism of the Pharmacy 
and Poisons Board.
3 Adequate investigation of the root causes of errors.
Q: Can technology make a 
difference in reporting or dealing 
with medical errors?
mHealth applications might increase 
efficiency of reporting. In this instance, 
we have used mHealth and social 
media to publicise and discuss the 
issue within the eye care community.   
Medication error affecting newborns’ 
sight: a national response 
There have been several reports in 
Kenya of the wrong use of chlorhexidine 
digluconate solution 7.1% in the eyes of 
babies, resulting in chemical injury. 
Nyawira Mwangi spoke with Michael 
Gichangi, lead ophthalmologist at Kenya’s 
Ministry of Health, about this problem.
Chlorhexidine 7.1% is toxic to the cornea. KENYA
Nyawira Mwangi
Research Fellow: 
London School of 
Hygiene and Tropical 
Medicine, London, 
UK.
Michael Mbee 
Gichangi
Head: Ophthalmic 
Services Unit: 
Ministry of Health, 
Nairobi, Kenya.
Chlorhexidine ointment can be 
mistaken for eye ointment. 
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